The cover story of this issue of Pharmaceutical Technology is devoted to over-the-counter (OTC) medications—how they're regulated, and what safeguards are in place to help ensure their quality and ...

Qualitest Pharmaceuticals Issues Voluntary, Nationwide Retail Level Recall of Four Lots of Butalbital, Acetaminophen, and Caffeine Tablets, USP 50mg/325mg/40mg and Four Lots of Hydrocodone Bitartrate ...

With OTCs challenging traditional approaches to quality, new opportunities are arising to support industry innovation and advance public health. Over-the-counter medicines (OTCs) occupy an important ...

FOR IMMEDIATE RELEASE - June 24, 2011 - Endo Pharmaceuticals today issued a voluntary nationwide consumer level recall of Endocet® (oxycodone/acetaminophen, USP) Tablets, 10 mg/325 mg 100 count ...

An individual bottle of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10mg/500mg, NDC 0603-3888-20, 60 count, was found to be incorrectly labeled with a Phenobarbital Tablets, USP 32.4 mg, NDC ...

According to IMS, the total sales of Oxycodone and Acetaminophen tablets (USP, 5-mg/325 mg and 10-mg/325 mg) in the US for the 12-month ending July 2017 reached nearly $571 million, at Average ...

This drug is administered in the form of a tablet, through an oral intake. Hydrocodone Bitartrate is an opioid analgesic and antitussive and occurs as fine, white crystals or as a crystalline powder.

Watson Laboratories, Inc. today issued a voluntary nationwide recall for two lots of Hydrocodone Bitartrate and APAP Tablets, USP 10 mg/500 mg. A customer complaint was received for tablets that were ...

PRINCETON, N.J., Aug. 20 -- Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug ...